Investigational Site Number :8400002 — Los Angeles, California

Investigational Site Number :8400002 is a clinical research site located in Los Angeles, California, United States 90024.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number :8400002 has participated in 2 clinical trials.

Therapeutic areas: Alport Syndrome, Dermatitis Atopic.

Sponsors: Genzyme, a Sanofi Company, Sanofi.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number :8400002?

Investigational Site Number :8400002 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number :8400002 conducted?

Investigational Site Number :8400002 has 2 clinical trials on record. Their work covers Alport Syndrome, Dermatitis Atopic.

Is Investigational Site Number :8400002 accredited by Crixeo Health?

Investigational Site Number :8400002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number :8400002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.